Accueil>>Avotaciclib trihydrochloride

Avotaciclib trihydrochloride (Synonyms: BEY1107 trihydrochloride)

Catalog No.GC26324

Avotaciclib (BEY1107) trihydrochloride is an effective and orally active cyclin dependent kinase 1 (CDK1) inhibitor. 

Products are for research use only. Not for human use. We do not sell to patients.

Avotaciclib trihydrochloride Chemical Structure

Cas No.: 1983984-01-5

Taille Prix Stock Qté
1mg
139,00 $US
En stock
5mg
306,00 $US
En stock
10mg
486,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Avotaciclib (BEY1107) trihydrochloride is an effective and orally active cyclin dependent kinase 1 (CDK1) inhibitor. Avotaciclib trihydrochloride can be used to study locally advanced or metastatic pancreatic cancer.

Avis

Review for Avotaciclib trihydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Avotaciclib trihydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.